Gene amplification has been associated with multidrug resistance (MDR) in several drug-resistant Chinese hamster ovary (CHO) cell lines which exhibit cross-resistance to other unrelated, cytotoxic drugs. In situ hybridization studies (Teeter et al., J. Cell Biol., in press) suggested the presence of an amplified gene associated with the MDR phenotype on the long arm of either of the largest CHO chromosomes (1 or Z1) in vincristine-resistant cells. In this study, somatic cell hybrids were constructed between these vincristineresistant CHO cells and drug-sensitive murine cells to determine the functional relationship between the chromosome bearing the amplified sequences and the MDR phenotype. Hybrids exhibited primary drug resistance and MDR in an incomplete dominant fashion. Hybrid clones and subclones segregated CHO chromosomes. Concordant segregation between vincristine resistance, the MDR phenotype, the presence of the MDR-associated amplified sequences, overexpression of the gene located in those sequences, and CHO chromosome Zl was consistent with the hypothesis that there is an amplified gene on chromosome Zl of the vincristine-resistant CHO cells which is responsible for the MDR in these cells. A low level of discordance between CHO chromosomes Z8 and 2 and the drug resistance phenotype suggests that these chromosomes may contain genes involved with the MDR phenotype.
Gene amplification has been associated with multidrug resistance (MDR) in several drug-resistant Chinese hamster ovary (CHO) cell lines which exhibit cross-resistance to other unrelated, cytotoxic drugs. In situ hybridization studies (Teeter et al., J. Cell Biol., in press) suggested the presence of an amplified gene associated with the MDR phenotype on the long arm of either of the largest CHO chromosomes (1 or Z1) in vincristine-resistant cells. In this study, somatic cell hybrids were constructed between these vincristineresistant CHO cells and drug-sensitive murine cells to determine the functional relationship between the chromosome bearing the amplified sequences and the MDR phenotype. Hybrids exhibited primary drug resistance and MDR in an incomplete dominant fashion. Hybrid clones and subclones segregated CHO chromosomes. Concordant segregation between vincristine resistance, the MDR phenotype, the presence of the MDR-associated amplified sequences, overexpression of the gene located in those sequences, and CHO chromosome Zl was consistent with the hypothesis that there is an amplified gene on chromosome Zl of the vincristine-resistant CHO cells which is responsible for the MDR in these cells. A low level of discordance between CHO chromosomes Z8 and 2 and the drug resistance phenotype suggests that these chromosomes may contain genes involved with the MDR phenotype.
Effective pharmacologic treatment of neoplasia depends on the cytotoxic effects of chemotherapeutic agents on malignant cells. The emergance of cell populations nonresponsive to the cytotoxic effects of a variety of unrelated drugs presents a significant problem in cancer patient management. Clinical studies on mechanisms of drug resistance has historically focused on insights gained from cultured cell model systems.
Multidrug resistance (MDR) has now been well documented and has been shown to occur with high frequency in a variety of cultured systems exposed to vinca alkaloids or anthracycline antineoplastic agents (1, 2, 11, 12, 15) . The overproduction of a 175,000-dalton plasma membrane glycoprotein (termed P-glycoprotein) and the amplification of an evolutionarily conserved gene possibly encoding the Pglycoprotein have been reported in several independently established MDR cell lines (7, 8, 16, 18, 19 ; Teeter et al., J. Cell Biol., in press). In all cases of MDR studied, the same gene is either overexpressed or overexpressed and amplified (21) . This line of evidence suggests a link between the MDR phenomenon and the overexpressed, amplified gene and has led some investigators to term this gene the multidrug resistance gene (21) . However, definitive evidence for the involvement of this amplified DNA sequence with MDR remains elusive.
In the present study, we have approached the MDR problem through analysis of somatic cell hybrids formed between drug-sensitive murine cells and Chinese hamster ovary (CHO) cells exhibiting MDR. The evidence presented here further indicates a functional relationship between the * Corresponding author. overexpressed gene and the MDR phenotype, since the loss of the chromosome harboring this gene confers phenotypic drug sensitivity on otherwise resistant hybrids.
MATERIALS AND METHODS
Cell lines and culture conditions. Parental and hybrid cell lines used in this study were maintained as monolayer cultures at 37°C and 5% CO2 in Dulbecco modified Eagle medium (Gibco) supplemented with 10% fetal bovine serum (Hazelton). Cell lines VCR5 and VCR15 are vincristineresistant (VCR) CHO cells which exhibit cross-resistance to a variety of drugs, including puromycin, ethidium bromide, Colcemid, and Adriamycin. Details of their derivation and characterization have been described elsewhere (11; Teeter et al., in press). VCR5 and VCR15 were maintained in the presence of 5 and 15 ,ug of vincristine (Sigma) per ml, respectively. We established a VCR mouse cell line by stepwise selection of murine CliD cells in vincristine by the following regimen: 0.03 to 0.06 to 0.09 ,ug/ml; the first two steps were for 3 days each, and selection in 0.09 ,ug/ml continued until resistant clones formed (about 2 weeks). Further selection to VCR1.0 continued as follows: 0.09 to 0.25 to 0.5 to 1.0 ,ug/ml, each selection step lasting about 1 month.
Establishment of hybrids. Hybrid cells were formed by plating CHO, VCR5, or VCR15 cells with thymidine kinasedeficient murine CliD cells at a ratio of 1:1 and fused by the polyethylene glycol-mediated procedure described by Davidson et al. (5) . After fusion, cells were incubated in nonselective medium overnight and then subjected to one of the following selection schemes: (i) HAT (10-4 M hypoxan-thine, 10' M aminopterin, and l0-5 M thymidine) plus ouabain (10-3 M) (when Ouar C11D cells were used); (ii) HAT plus vincristine (1 ,ug/ml); or (iii) HAT alone. Cells were grown in selection medium for over 2 weeks. Surviving clones were isolated with cloning cylinders.
One hybrid clone, generated via selection scheme i, was subjected to further selection in the presence of diphtheria toxin (DT) at 0.5 floculating unit (LF) per ml by the strategy of Roberts and Ruddle (17) . We have successfully used this strategy to select for segregants of CHO chromosome 2, which harbors a diptheria toxin sensitivity locus (25) . Segregants of chromosome 2 cosegregate chromosome 1 with high frequency (25) . Cytotoidcity analysis. Drug dose response analysis was performed by plating 500 cells in 3.5-cm dishes in regular medium containing various concentrations of vincristine or Colcemid (Gibco). Analysis was done on parental cell lines and hybrid cell lines derived by selection scheme i.
Cytogenetic and isozyme analyses. G-band chromosome analysis of hybrid subclones was performed on conventionally prepared air-dried slides by the technique of Seabright (20) . G-banded CHO chromosomes were identified by the nomenclature of Deaven and Petersen (6) .
Hybrid subclones were examined by vertical starch gel electrophoresis for the presence of the following CHO isozymes (with abbreviations and CHO chromosome assignment indicated parenthetically): adenosine deaminase (ADA; Z8, Z9), adenosine kinase (ADK; 1, Z1), acid phosphatase 1 (ACP1; 7, Z8), adenine phosphoribosyltransferase (APRT; Z4, Z7), esterase D (ESD; (1, Z6) , enolase 1 (ENOI; 2, Z2), a-glucosidase (GAA; Z3, Z4), galactokinase (GALK; 7, Z13), galactose-1-phosphate uridyltransferase (GALT; 2), glyoxalase (GLO; 1, Z1), glucose-6-phosphate dehydrogenase (G6PD; 2, Z2), glucose phosphate isomerase (GPI; 9), glutathione reductase (GSR; 1, Z1), isocitrate dehydrogenase (IDH2; Z3), inosine triosephosphatase (ITPA; Z8, Z9), lactate dehydrogenase (LDHA; Z3, Z4), malic enzyme 1 (MEl; Z5, Z7), mannose phosphate isomerase (MPI; Z5, Z7), nucleoside phosphorylase (NP; 1, Z1), peptidase B, C, D, and S (PEPB [1, Z1], PEPC [5, Z6] , PEPD [9] , PEPS [1, Zl]), phosphoglucomutase 1, 2, and 3 (PGMI [2, Z2], PGM2 [1, Zl] , PGM3 [Z6, Z7]), pyruvate kinase 2 (PKM2; Z5, Z7), and triosephosphate isomerase (TPI; 8). Procedures for histochemical examination of these loci have been described previously (9, 22, 24) . Chromosomal assignment of these loci in CHO cells has been described previously (23) .
Southern and Northern hybridizations. For Southern hybridization, 10 ,ug of EcoRI (Boehringer Mannheim)-digested genomic DNAs were electrophoresed on 1% agarose gels, transferred to nitrocellulose filters (Millipore), hybridized to plasmid probe pDR2-4, and washed as described previously (Teeter et al., in press). For Northern hybridization, 10 ,ug of total polyadenylated poly(A)+ RNA, isolated as described by Chirgwin (4) and fractionated by oligo(dT)-cellulose chromatography, was electrophoresed on denaturing 1.2% agarose gels with glyoxal, transferred to GeneScreen membranes (New England Nuclear), hybridized, and washed as described previously (Teeter et al., in press). The pDR2-4 plasmid DNA clone is a repeat-free subclone of the cosmid clone pDR6 isolated from the VCR15 genomic DNA library with pDR1.1 (18) clone as the probe. The pDR2-4 plasmid DNA contains DNA sequences that detect DNA sequences similar, if not identical, to the P-glycoprotein gene (16; Teeter et al., in press). Details of the isolation and characterization of pDR2-4 will be described elsewhere (Teeter et al., in press).
RESULTS
Resistance and cross-resistance of hybrids. CHO-mouse cell hybrids were generated via selection scheme i described in Materials and Methods. Both wild-type CHO and VCR5 cells were fused in parallel experiments to murine CliD cells. The hybrids resulting from the CHO-CliD cell fusions were termed the A-series (e.g., A9, A19, and A20) and those resulting from the VCR5-Cl1D cell fusions were termed the F-series (e.g., FlA, F4A, and F5A). Figure 1 shows the dose-response profile of these hybrids and their parents to vincristine and Colcemid. These experiments were done about 3 weeks after hybrid colonies were cloned to minimize the possibility of chromosome segregation. The F-series hybrids derived from the drug-resistant VCR5 cells were also resistant to vincristine (Fig. 1A) . The A-series hybrids, wild-type CHO line, and CliD cells showed marked vincristine sensitivity. However, the level of resistance for the F-series hybrid cells was lower than that for VCR5 cells. This result suggests that the hybrids acquired only partial resistance from VCR5 cells (i.e., resistance is acquired in an incomplete dominant fashion).
Cross-resistance studies ( Fig. 1B) showed that the Fseries hybrids also exhibited cross-resistance to Colcemid. Again, the levels of resistance exhibited by these clones were between those for the sensitive and resistant parental lines, suggesting incomplete dominance with respect to cross-resistance. Consistent with previous observations, the A-series hybrids remained sensitive to Colcemid at levels similar to those of the sensitive parents. Similar results were observed when the functionally unrelated drugs puromycin and ethidium bromide were used (not shown). These results show that the MDR phenotype in F-series hybrids was inherited from VCR5 cells and was not due to a simple heterokaryon formation phenomenon.
Generation of hybrid clone panel. A hybrid clone panel consisting of 28 clones or subclones resulting from VCR-CllD cell fusions was assembled. Each panel member had a different CHO chromosome complement, as judged by cytogenetic or isozyme analysis or both, and could therefore be judged as an independent segregant.
Due to the slow rate of segregation of CHO chromosomes in these fusions, various strategies (listed below) were used to generate the hybrid clone panel members: (i) subclones of F-series clone FlA after growth for several months to allow chromosome segregation (scheme A, Table 1 ); (ii) DTresistant subclones of FlA after a similar period of growth to select for chromosome 2 segregants (see Materials and Methods) (scheme B); (iii) clones or subclones resulting from VCR15-ClD fusions and selection according to scheme ii (HAT plus vincristine) (scheme C); and (iv) subclones of clones resulting from VCR15-ClD fusions and selection according to scheme iii (HAT only) (scheme D). whether there was a correlation between the MDR phenotype and the presence of the amplified gene among the panel members. For these purposes, we used pDR2-4, a repeatfree plasmid subclone containing coding sequences of an amplified gene in the MDR line VCR15, as described elsewhere (Teeter et al., in press). For each panel member exhibiting MDR, amplification of this gene was evident (Fig.  2) . Similarly, for each panel member shown to have segregated the MDR phenotype, no hybridization signal was detected. Table 1 summarizes these results, indicating 100% concordance between MDR and amplification of the putative amplified MDR gene among hybrid panel members. In all the MDR hybrid clones analyzed, approximately 40-fold amplification of the pDR2-4 sequences was present (lanes 3 to 7). This level of amplification is consistent with that in the parental VCR15 (lane 2) cells. Conversely, no hybridization signal was detected in drug-sensitive clones (lanes 8 to 11). Figure 2 , lane 1, shows the hybridization pattern of DNA from an MDR mouse CliD cell line selected for resistance to vincristine to the hamster probe. Note that the size of the hybridized fragment was larger than that for VCR15 and the hybrids (7 kilobases [kb] versus 4 and 4.6 kb, respectively). We therefore conclude that the amplified DNA in these hybrids was of CHO origin rather than a spontaneous amplification of putative mouse MDR genes.
Northern hybridization analysis was performed to investigate whether the amplified gene was overexpressed in some of the resistant hybrids. Figure 3 Chromosome segregation analysis. As will be published elsewhere (Teeter et al., in press), we localized the amplified gene to either CHO chromosome 1 or Zl in our VCR15 cells by in situ hybridization. In this study, we analyzed the chromosome complements of our hybrid clone panel to investigate whether CHO chromosome 1 or Zl is correlated with the MDR phenotype. Table 2 shows a concordance-discordancy analysis for members of the hybrid panel with respect to vincristine and Adriamycin resistance and the presence of CHO chromosomes as determined by cytogenetic or biochemical-genetic means. The total number of clones scored for each chromosome varied among clones, since not all chromosomes could be unambiguously scored by isozyme marker loci. This complication was due to preexisting chromosomal translocations and rearrangements of the Chinese hamster karyotype during formation of the CHO cell line (6) . Thus, the presence of isozyme markers on more than one chromosome (23) made unambiguous identification difficult.
The results of the discordancy analysis were essentially ance, respectively, whereas chromosome 1 was highly discordant (57 and 41%, respectively). These results suggest a role for chromosome Zl in the MDR phenotype in VCR CHO cells. Of the two clones discordant with the Zl, clone FDC3, an MDR-negative line, contained the Zl chromosome by isozyme analysis (had typical chromosome 1 isozyme but lacked ESD, which is on 1 but not Z1) but showed negative hybridization to the pDR2-4 probe in the Southern blot ( Table 1 ). The other discordant clone, FVB3, was MDR positive but exhibited no Zi chromosome by isozyme and cytogenetic analysis, while showing positive hybridization to the amplified probe (Table 1 ). Since we have demonstrated that the hybridization probe detects DNA sequences on chromosomes 1 and Zi by in situ hybridization (Teeter et al., in press), we conclude that rearrangements or translocations have occurred in these discordant hybrids. Chromosomes 2 and Z8 also exhibited low discordance frequencies with respect to MDR, 14 and 18%, respectively, for vincristine resistance and 19 and 20%, respectively, for Adriamycin resistance ( Table 2 ). All 28 hybrids could be unambiguously scored for chromosome 2 by isozyme analysis, and only two segregants were seen. The contribution of the nonsegregant (+/+) group, therefore, gave an abnormally low discordant frequency. The low discordance frequency for chromosome Z8 stems from the low number of clones that could be unambiguously scored by isozyme analysis (for reasons described above). Nevertheless, the possibility that another genetic trait(s) may be present on chromosome 2 or Z8 which contributes to the MDR phenotype cannot be rigorously ruled out at present.
DISCUSSION
It is generally known that gene mapping on CHO chromosomes by the somatic cell hybridization approach is technically difficult because CHO cell hybrids with either human or mouse cells usually yield segregants of mouse or human chromosomes rather than hamster chromosomes. Some hamster chromosomes (2, for example) segregate even less frequently than others. Furthermore, the abnormal CHO chromosomes (termed Z chromosomes) in the hybrids complicate the analysis of chromosomes either by isozyme analysis or by cytogenetic observations. Despite these difficulties, we have described in this communication our efforts to determine the genetic determinants on CHO chromosomes that confer the MDR phenotype. Several important conclusions can be made from the study described here. In fusions between MDR CHO cells primarily selected for resistance to vincristine and drug-sensitive murine cells, the resultant hybrids were both vincristine resistant and crossresistant to other drugs. Both resistance and cross-resistance were conferred in an incomplete manner, consistent with observations made with colchicine-resistant cells exhibiting MDR (1, 13) . This phenomenon may be due to gene dose effects resulting from either the inherent heterogeneity of hybrid clones (i.e., some cells may have segregated the responsible chromosome) or a functional reduction in the level of amplification by heterokaryon formation. Alternatively, partial reversion to drug sensitivity could be due to partial loss of amplified gene copies during the time needed for selection and cloning of hybrids.
Our results show a 100% correlation between retention of the MDR phenotype and the amplified gene in the hybrids studied. These results, along with results from independently derived cell lines (8, 18, 19, 21; S. Sen, L. Teeter, and T. Kuo, manuscript in preparation), further implicate this gene in the maintenance of the MDR phenotype.
Among the 21 hybrid panel members investigated, each time vincristine resistance segregated, cross-resistance cosegregated. This suggests either a syntenic relationship between the two phenotypes or that one locus is responsible for both phenotypes. We note that our results are in contrast with those demonstrated by other investigators (1) with a human MDR system, in which, in one hybrid clone, primary resistance and cross-resistance segregated independently. Our criteria for drug resistance tests were based on one concentration of drug which permitted a survival frequency of less than l0' in CHO cells. We have not determined in these MDR hybrid clones the dose response (50% effective dose) to these drugs for a more precise measurement of levels of resistance.
We have previously implicated an amplified domain on chromosome 1 or Zl in our VCR1.5 and VCR15 cell lines by in situ hybridization. VCR1.5 cells contained extrachromosomal bodies known as double minutes (DM) in 50% of cells, whereas in the VCR5 and VCR15 cell lines that were used for hybrid formation in the present study, less than 2% of the cells contained DM (Teeter et al., in press). We also noted that the Zl chromosome of both the VCR5 and VCR15 cell lines contained abnormally banding regions, as analyzed by the Giemsa-trypsin banding technique. Using discordancy analysis for MDR and CHO chromosomes in a 28-member hybrid clone panel, we have functionally implicated the involvement of CHO chromosome Zl (not 1) with the MDR phenotype in the vincristine-resistant parental lines (i.e., the loss of the amplified domain on chromosome Zl confers phenotypic sensitivity on the hybrids). However, in an independently established MDR CHO line selected for primary resistance to Adriamycin, we noted amplification on chromosome 1, not Zl (Sen et al., in preparation). This result suggests that the normal residence for the putative MDR gene is on homologous areas of chromosomes 1 and Zl and that either locus can be amplified by selection. These results are consistent with those obtained for other independently established MDR Chinese hamster cell lines (3, 26) .
Our chromosome discordance analysis of the hybrid clone panel revealed that chromosomes 2 and Z8 also exhibit a low discordance frequency with the MDR phenotype. Due to technical difficulties (mentioned above), we cannot rule out that other genetic loci located on these chromosomes may be involved with MDR at present. Additional studies are required to resolve this question. As mentioned above, our probe detects gene sequences similar, if not identical to, that encoding the P-glycoprotein.
Additionally, high levels of P-glycoprotein have been detected in our VCR CHO cells (VCR5) and those indepen-dently established in several other laboratories (10) . Despite the 100% concordance between the MDR phenotype and the presence of the amplified gene in the hybrid clone panel, whether the amplified gene alone can confer the MDR phenotype has yet to be proven by a DNA-mediated gene transfer method with the cloned amplified gene in an expressible vector. At present, we suspect that other loci may work in concert with the P-glycoprotein gene in conferring the MDR phenotype. This is based on our observation that the level of amplification of the MDR-associated gene and its expression are not strictly correlated with the levels of drug resistance in MDR CHO cells (Teeter et al., in press).
Furthermore, the fact that MDR cell lines usually show the highest level of resistance to the primary selecting agent supports the notion that other genes may be involved in the establishment of resistance to particular cytotoxic agents (Teeter et al., in press; Sen et al., in preparation). In this regard, the cytosolic protein V19, which has frequently been shown to be overproduced in a number of independently established MDR lines (14) , may be involved in this phenomenon. Further studies to clarify this possibility are required.
